SCHEMBL6002534

SCHEMBL6002534

Clc1ccc([CH]C2CCNCC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 2/20 0.44
HTR3E A5X5Y0 1/20 0.38
HTR3B O95264 1/20 0.38
ADRB1 P08588 1/20 0.38
HTR3D Q70Z44 1/20 0.38
HTR3C Q8WXA8 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SLC6A3 Q01959 1/20 0.37
HSD17B10 Q99714 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
DRD2 P14416 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP19A1 P11511 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1119465 0.85 HSD17B10 (0.44) HTR3AHSD17B10CYP1A2PIM1PIM2
SCHEMBL11097338 0.81 HSD17B10 (0.41) HTR3AHSD17B10NPC1RAB9ACYP1A2
SCHEMBL10069269 0.81 MAOB (0.51) HTR3ACYP1A2
SCHEMBL7249057 0.80 SLC6A2 (0.39) SLC6A2SLC6A4SLC6A3IKBKB
SCHEMBL6002937 0.79 SLC18A3 (0.48) SIGMAR1CYP2D6HTR2C
SCHEMBL8138970 0.79 KMT2A (0.40) HSD17B10NPC1RAB9ACYP1A2
SCHEMBL8481040 0.76 AKT1 (0.39) SLC6A2SLC6A4SLC6A3NPC1RAB9A
SCHEMBL19616105 0.73 MAOB (0.36) HSD17B10PIM1PIM2
SCHEMBL27697688 0.72 EPHX1 (0.47) SLC6A4CYP2D6HTR2AHTR2CHTR2B
SCHEMBL493565 0.72 CNR1 (0.40) SLC6A2SLC6A4SLC6A3HSD17B10NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed